Anhui Huaren Health Pharmaceutical Co., Ltd.

¥13.81As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301408Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR (9.58%)
Div yield 0.72%
ROE 12.45%
Pharmaceutical Retailers
Beta (5Y) 0.75
PE TTM 22.01
TSR TTM 3.52%
Mkt cap ¥5.524B
ROIC 13.36%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥16
18.66%
(41.19%)
Sell 0|12|6|2|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.19
0.20
0.22
0.24
(3.65%)
7.35%
9.00%
20.10%
Revenue¥M
292.9
299.7
309.9
327.5
11.48%
11.62%
9.73%
18.25%
Peers (US$828.1M)
Cap (US$)
PE
871.9M
230.3x
555.0M
13.61x
770.4M
34.16x
Capital
TTM
5Y
10Y
Leveragex
0.153
0.344
0.401
EBIT/Intx
2.436
0.212
0.195
Own earn%
(96.56)
(78.63)
(63.12)
Sh yield%
17.43
51.05
50.74
Owners
Insiders/Inst%
0.44
56.12
Short interest%
3.28
SBC / revenue%
3.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
13–19
$1 testx
−0.8
Incr. ROIC%
9